A Single Arm, Multi-center Phase II Study of RAD001 in Patients With Advanced Gastric Carcinoma Whose Cancer Has Progressed Despite Prior Treatment.

Trial Profile

A Single Arm, Multi-center Phase II Study of RAD001 in Patients With Advanced Gastric Carcinoma Whose Cancer Has Progressed Despite Prior Treatment.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Nov 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 13 Jan 2009 Results reported at ASCO Gastrointestinal Cancers Symposium, according to a Novartis media rlease.
    • 30 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top